Your browser doesn't support javascript.
loading
Impaired Insulin Clearance as the Initial Regulator of Obesity-Associated Hyperinsulinemia: Novel Insight Into the Underlying Mechanism Based on Serum Bile Acid Profiles.
Fu, Zhenzhen; Wu, Qinyi; Guo, Wen; Gu, Jingyu; Zheng, Xuqin; Gong, Yingyun; Lu, Chenyan; Ye, Jingya; Ye, Xuan; Jiang, Wanzi; Hu, Moran; Yu, Baowen; Fu, Qi; Liu, Xiang; Bai, Jianling; Li, John Zhong; Yang, Tao; Zhou, Hongwen.
Afiliação
  • Fu Z; Department of Endocrinology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
  • Wu Q; Department of Endocrinology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
  • Guo W; Department of Health Promotion Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
  • Gu J; Department of Endocrinology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
  • Zheng X; Department of Endocrinology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
  • Gong Y; Department of Endocrinology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
  • Lu C; Department of Endocrinology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
  • Ye J; Department of Endocrinology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
  • Ye X; Department of Endocrinology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
  • Jiang W; Department of Endocrinology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
  • Hu M; Department of Endocrinology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
  • Yu B; Department of Endocrinology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
  • Fu Q; Department of Endocrinology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
  • Liu X; Beijing Academy of Artificial Intelligence, Beijing, China.
  • Bai J; College of Future Technology, Peking University, Beijing, China.
  • Li JZ; Department of Biostatistics, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu, China.
  • Yang T; The Key Laboratory of Rare Metabolic Disease, Department of Biochemistry and Molecular Biology, The Key Laboratory of Human Functional Genomics of Jiangsu Province, Nanjing Medical University, Nanjing, Jiangsu, China.
  • Zhou H; Department of Endocrinology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
Diabetes Care ; 45(2): 425-435, 2022 02 01.
Article em En | MEDLINE | ID: mdl-34880066

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Resistência à Insulina / Hiperinsulinismo Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Diabetes Care Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Resistência à Insulina / Hiperinsulinismo Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Diabetes Care Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China